|
Market Closed -
Other stock markets
|
After hours 17:13:33 | |||
| 98.93 USD | -0.79% |
|
98.88 | -0.05% |
| 09:30am | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 07:29am | Saskatchewan adds Capvaxive to publicly funded adult immunization program | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.79% | -2.85% | +14.04% | +17.65% | -0.55% | -4.68% | -10.75% | +18.93% | +85.02% | 248B | |
| -1.26% | -5.70% | +3.20% | +35.06% | +29.22% | +24.14% | +168.32% | +568.18% | +1,054.48% | 905B | |
| -0.15% | -1.81% | +7.01% | +13.19% | +39.41% | +34.77% | +13.78% | +33.04% | +96.86% | 487B | |
| -1.31% | -0.88% | +2.02% | +6.35% | +25.56% | +26.36% | +34.42% | +107.19% | +293.72% | 400B | |
| +2.19% | +3.35% | +18.37% | +15.86% | +24.34% | +23.62% | +5.48% | +4.35% | +15.78% | 330B | |
| -0.10% | -2.83% | +5.26% | +12.31% | +29.71% | +27.45% | +20.61% | +68.23% | +202.84% | 281B | |
| -0.41% | +2.07% | +4.55% | +2.56% | +20.23% | +18.74% | +24.32% | +31.17% | +24.36% | 255B | |
| -3.42% | -5.68% | +2.68% | -14.57% | -52.10% | -61.94% | -32.73% | +42.72% | +51.05% | 214B | |
| -2.63% | -4.82% | -0.75% | +14.65% | +23.25% | +15.70% | +12.49% | +40.31% | +101.59% | 178B | |
| -0.02% | -2.53% | +2.57% | +4.58% | +31.20% | +33.78% | +35.45% | +98.12% | +17.06% | 150B | |
| -1.00% | +1.98% | +5.66% | +4.97% | -2.86% | -1.26% | -50.23% | -39.45% | -20.78% | 148B | |
| -1.65% | -2.52% | -2.15% | +5.16% | -10.82% | -9.31% | -7.73% | +0.94% | +4.27% | 120B | |
| -2.95% | +3.86% | +4.95% | +11.84% | +9.77% | -6.74% | +37.57% | +92.33% | +258.54% | 116B | |
| -0.92% | +5.06% | +9.33% | +10.60% | -8.65% | -11.99% | -35.32% | -15.46% | -25.55% | 106B | |
| +0.86% | +1.65% | +2.94% | +23.34% | +35.20% | +35.45% | +21.98% | +4.19% | +10.04% | 96.56B | |
| -0.11% | -1.79% | +10.12% | +24.32% | +17.50% | +22.22% | +125.32% | +63.24% | +471.11% | 87.18B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -6.13% | -5.40% | -2.64% | -5.50% | +82.75% | +68.05% | +80.67% | +235.82% | +325.64% | 60.52B | |
| +1.36% | +0.61% | +1.43% | -13.81% | +36.08% | +26.11% | +53.92% | -16.61% | +292.17% | 57.93B | |
| +1.11% | -1.04% | +6.67% | -2.51% | +6.65% | +8.15% | +11.47% | +15.22% | -25.65% | 44.82B | |
| Average | -0.85% | -0.50% | +5.01% | +8.74% | +17.68% | +14.14% | +26.79% | +71.18% | +170.13% | 217.38B | |
| Weighted average by Cap. | -0.79% | -1.91% | +5.52% | +14.36% | +20.00% | +16.58% | +46.26% | +154.16% | +313.14% |
- Stock Market
- Equities
- MRK Stock
- Sector Merck & Co., Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition